1.

2020 FDA/EMA approvals for new immunotherapy drug technologies and applications

دوره 7، شماره 2، شهریور 2021، صفحه 81-92
Maryam Monajati؛ Samira Sadat Abolmaali؛ Alimohammad Tamaddon

2.

Arteether Exerts Antitumor Activity and Reduces CD4+CD25+FOXP3+ T-reg Cells in Vivo

دوره 10، شماره 3، آذر 2013، صفحه 139-149
Maryam Azimi Mohamadabadi؛ Zuhair Mohammad Hassan؛ Ahmad Zavaran Hosseini؛ Mehrdad Gholamzad؛ Shekoofe Noori؛ Mehdi Mahdavi؛ Hamidreza Maroof

3.

Combined Extract of Heated 4T1 and a Heat-Killed Preparation of Lactobacillus Casei in a Mouse Model of Breast Cancer

دوره 42، شماره 5، آذر 2017، صفحه 457-464
Sajjad Jafari؛ Seyyed Meysam Abtahi Froushani؛ Amir Tokmachi

4.

CTLA-4 blockade in the treatment of colorectal cancer with microsatellite instability

دوره 9، شماره 1، خرداد 2021، صفحه 1-6
Diana Russo؛ Francisco Mendes

5.

Dendritic Cell Maturation with CpG for Tumor Immunotherapy

دوره 3، شماره 3، آذر 2006، صفحه 99-105
Samaneh Arab؛ Masoumeh Motamedi؛ Nematollah Khansari؛ Seied Mohammad Moazzeni؛ Zahra Gheflati؛ Jamshid Hadjati

6.

Dendritic Cells and Their Role in Cancer Immunotherapy

دوره 4، شماره 3، اسفند 2007، صفحه 127-144
Ahmad Jalili

7.

Effects of Dendritic Cell Vaccine Activated with Components of Lieshmania Major on Tumor Specific Response

دوره 16، شماره 4، اسفند 2019، صفحه 268-277
Samaneh Arab؛ Masoumeh Motamedi؛ Jamshid Hadjati

8.

Immune Checkpoint Inhibitors-induced Thyroid Dysfunction in Patients with Advanced Malignancies

دوره 13، شماره 4، دی 2022، صفحه 616-623
Muhammad Farooq Latif؛ Elamin Abdelgadir؛ Mohamed Omara؛ Fauzia Rashid؛ Syed H Tirmazy؛ Faraz Khan؛ Maroun El Khoury؛ Alaaeldin Bashier؛ Fatheya Alawadi؛ Kaltar Das؛ Susheel Kumar؛ Abdul Q Basit؛ Dalia El-Shourbagy؛ Dina Hamza؛ Faisal Azam

9.

Immune Targeted Therapies for COVID-19 Infection: A Narrative Review

دوره 47، شماره 4، مهر 2022، صفحه 291-299
Bahareh Forouzani-Haghighi؛ Alireza Rezvani؛ Afsaneh Vazin

10.

Immunotherapy in Metastatic Malignant Melanoma and Non-Small Cell Lung Cancer; a Brief Review and Position Statement from the Immuno-Oncology Clinical Forum (IOCF), Iran

دوره 2، شماره 1، خرداد 2016، صفحه 190-196
Arafat Tfayli؛ Hamid Attarian؛ Mojtaba Ghadyani؛ Atabak Ghotb؛ Mehrdad Mashadian؛ Babak Salimi؛ Sadegh Sedaghat؛ Mohammad Seghatoleslami؛ Sharareh Seifi؛ Mohammad Torabi-Nami

11.

Immunotherapy to Address Unmet Needs in Oncology; Two Clinical Vignettes of Response in Metastatic Malignant Melanoma and Non-Small Cell Lung Cancer

دوره 1، شماره 2، اسفند 2015، صفحه 116-119
Arafat Tfayli؛ Mohammad Torabi-Nami؛ Atabak Ghotb

12.

Listeria Monocytogenes Activated Dendritic Cell Based Vaccine for Prevention of Experimental Tumor in Mice

دوره 5، شماره 1، خرداد 2008، صفحه 36-44
Masoumeh Khamisabadi؛ Samaneh Arab؛ Masoumeh Motamedi؛ Nematollah khansari؛ Seied Mohammad Moazzeni؛ Zahra Gheflati؛ Jamshid Hadjati

13.

Methylation Profile of Cancer Testis Antigens in Colorectal Cancer

دوره 20، شماره 1، خرداد 2023، صفحه 83-91
Nadiah Abu؛ Nurul Ainaa Adilah Rus Bakarurraini؛ Siti Nurmi Nasir؛ Muhiddin Ishak؛ Rashidah Baharuddin؛ Rahman Jamal؛ Nurul Syakima Ab Mutalib

14.

Polyclonal Antibody against Different Extracellular Subdomains of HER2 Induces Tumor Growth Inhibition in vitro

دوره 14، شماره 3، آذر 2017، صفحه 200-214
Reza Hosseini-Ghatar؛ Tahereh Soltantoyeh؛ Motahareh Bahadori؛ Jalal Khoshnoodi؛ Forough Golsaz-Shirazi؛ Mahmood Jeddi-Tehrani؛ Mohammad Mehdi Amiri؛ Fazel Shokri

15.

Recent Progress in Allergen Immunotherapy

دوره 5، شماره 1، خرداد 2008، صفحه 1-24
Kayhan T Nouri-Aria

16.

Severe Acute Kidney Injury Secondary to Immunoglobulin Infusion in Life-Threatening Guillain Barre Syndrome

دوره 10، شماره 1، فروردین 2022، صفحه 44-48
José David D Orquera؛ Maria Marta Pernasetti؛ Patricia Ojeda؛ Griselda Aguero؛ Daniel Agustin Godoy

17.

Top 100 Most Cited Publications on CTLA-4 Molecule in Cancer Research: A Bibliometric Analysis

دوره 14، شماره 1، فروردین 2023، صفحه 1-16
Hossam Hilal El Idrissi؛ Ibtissam Balar

18.

Upregulation of Cytotoxic T-Lymphocyte-Associated Protein 4 and Forkhead Box P3 Transcripts in Peripheral Blood of Patients with Bladder Cancer

دوره 46، شماره 5، آذر 2021، صفحه 339-346
Ali Ariafar؛ Mojtaba Habibagahi؛ Mansooreh Jaberipour؛ Abdolaziz Khezri؛ Mohammad Hadi Khezri؛ Hale Bozorgi؛ Ahmad Hosseini؛ Mahboobeh Razmkhah

19.

Whole Tumor Cell Vaccine Adjuvants: Comparing IL-12 to IL-2 and IL-15

دوره 13، شماره 3، آذر 2016، صفحه 148-166
Abdolkarim Sheikhi؛ Abdollah Jafarzadeh؛ Parviz Kokhaei؛ Mohammad Hojjat-Farsangi



سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب